Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Authors / Magali Saint-Geniez and Patricia D’Amore

Magali Saint-Geniez and Patricia D’Amore

Magali is an Assistant Scientist at the Schepens Eye Research Institute, and an Assistant Professor of Ophthalmology at Harvard Medical School. Her research interests focus on the development of new strategies for the characterization and treatment of retinal degenerative diseases such as AMD. Magali also enjoys directing educational videos like “Can Treat This,” that tell the story of how to treat AMD (see http://top.txp.to/damore/amd). Patricia holds many learned positions at Harvard Medical School, including Director of Research at the Schepens Eye Research Institute; Vice Chair of Basic Research in Ophthalmology; the Charles L. Schepens Professorship of Ophthalmology; Professor of Pathology, and Co-Director of the AMD Center of Excellence. Patricia participates in the Susan G. Komen 3-Day, 60 miles walk. To date, she’s completed eight walks, totaling 480 miles in the process, plus another 1,500 miles in training.

  • Contributions

VEGF has Physiolgical as well as Pathological Functions

January 20, 2014

Growing evidence for the key role played by VEGF in the normal adult eye now demands that ophthalmologists give careful consideration to the use of anti-VEGF therapies. While these agents are highly effective for the treatment of ocular neovascularization – particularly as an anti-permeability factor – it may also interfere with the normal functions of VEGF in the eye.

1 min read

VEGF has Physiolgical as well as Pathological Functions

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: